Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism
The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell cytotoxicity to myeloma cells remains unclear. In the present study, we investigated the expressions of human leukocyte antigen (HLA) class I...
Saved in:
Published in | Acta biochimica et biophysica Sinica Vol. 46; no. 7; pp. 597 - 604 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
China
01.07.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell cytotoxicity to myeloma cells remains unclear. In the present study, we investigated the expressions of human leukocyte antigen (HLA) class I and HLA-G in patient myeloma cells, and determined their relevance in patient tumor-cell susceptibility to NK cell cytotoxicity. Our results showed that patient myeloma cells (n = 12) were relatively resistant to NK-92 cell lysis, compared with myeloma cell lines (n = 7, P 〈 0.01). Gene expression profiling and flow cytometry analysis showed that both mRNA and protein of HLA class I were highly expressed in 12 patient mycloma cells. Interestingly, no or low HLA-G surface expression was detected, although multiple HLA-G transcripts were detected in these mycloma cells. NK cell function assay showed that down-regulating HLA class I expression on patient cells by acid treatment significantly increased the susceptibility of MM cells to NK-mediated lysis. Furthermore, we found that the blocking of membrane-bound HLA class I rather than HLA-G using antibodies on myeloma samples markedly increased their susceptibility to NK-mediated killing. These results demonstrated that the resistance of patient MM cells to NK lysis mainly involves an I-ILA class l- dependent mechanism, suggesting that HLA class I may be involved in protecting MM cells from NK-mediated attack and contribute to their immune escape in vivo. |
---|---|
AbstractList | The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell cytotoxicity to myeloma cells remains unclear. In the present study, we investigated the expressions of human leukocyte antigen (HLA) class I and HLA-G in patient myeloma cells, and determined their relevance in patient tumor-cell susceptibility to NK cell cytotoxicity. Our results showed that patient myeloma cells (n = 12) were relatively resistant to NK-92 cell lysis, compared with myeloma cell lines (n = 7, P < 0.01). Gene expression profiling and flow cytometry analysis showed that both mRNA and protein of HLA class I were highly expressed in 12 patient myeloma cells. Interestingly, no or low HLA-G surface expression was detected, although multiple HLA-G transcripts were detected in these myeloma cells. NK cell function assay showed that down-regulating HLA class I expression on patient cells by acid treatment significantly increased the susceptibility of MM cells to NK-mediated lysis. Furthermore, we found that the blocking of membrane-bound HLA class I rather than HLA-G using antibodies on myeloma samples markedly increased their susceptibility to NK-mediated killing. These results demonstrated that the resistance of patient MM cells to NK lysis mainly involves an HLA class I-dependent mechanism, suggesting that HLA class I may be involved in protecting MM cells from NK-mediated attack and contribute to their immune escape in vivo. The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell cytotoxicity to myeloma cells remains unclear. In the present study, we investigated the expressions of human leukocyte antigen (HLA) class I and HLA-G in patient myeloma cells, and determined their relevance in patient tumor-cell susceptibility to NK cell cytotoxicity. Our results showed that patient myeloma cells (n = 12) were relatively resistant to NK-92 cell lysis, compared with myeloma cell lines (n = 7, P < 0.01). Gene expression profiling and flow cytometry analysis showed that both mRNA and protein of HLA class I were highly expressed in 12 patient myeloma cells. Interestingly, no or low HLA-G surface expression was detected, although multiple HLA-G transcripts were detected in these myeloma cells. NK cell function assay showed that down-regulating HLA class I expression on patient cells by acid treatment significantly increased the susceptibility of MM cells to NK-mediated lysis. Furthermore, we found that the blocking of membrane-bound HLA class I rather than HLA-G using antibodies on myeloma samples markedly increased their susceptibility to NK-mediated killing. These results demonstrated that the resistance of patient MM cells to NK lysis mainly involves an HLA class I-dependent mechanism, suggesting that HLA class I may be involved in protecting MM cells from NK-mediated attack and contribute to their immune escape in vivo. The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell cytotoxicity to myeloma cells remains unclear. In the present study, we investigated the expressions of human leukocyte antigen (HLA) class I and HLA-G in patient myeloma cells, and determined their relevance in patient tumor-cell susceptibility to NK cell cytotoxicity. Our results showed that patient myeloma cells (n = 12) were relatively resistant to NK-92 cell lysis, compared with myeloma cell lines (n = 7, P 〈 0.01). Gene expression profiling and flow cytometry analysis showed that both mRNA and protein of HLA class I were highly expressed in 12 patient mycloma cells. Interestingly, no or low HLA-G surface expression was detected, although multiple HLA-G transcripts were detected in these mycloma cells. NK cell function assay showed that down-regulating HLA class I expression on patient cells by acid treatment significantly increased the susceptibility of MM cells to NK-mediated lysis. Furthermore, we found that the blocking of membrane-bound HLA class I rather than HLA-G using antibodies on myeloma samples markedly increased their susceptibility to NK-mediated killing. These results demonstrated that the resistance of patient MM cells to NK lysis mainly involves an I-ILA class l- dependent mechanism, suggesting that HLA class I may be involved in protecting MM cells from NK-mediated attack and contribute to their immune escape in vivo. |
Author | Minjie Gao Lu Gao Guang Yang Yi Tao Jun Hou Hongwei Xu Xiaojing Hu Ying Han Qianqiao Zhang Xiaosong Wu Jumei Shi |
AuthorAffiliation | Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA 52242, USA |
Author_xml | – sequence: 1 givenname: Minjie surname: Gao fullname: Gao, Minjie organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China – sequence: 2 givenname: Lu surname: Gao fullname: Gao, Lu organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China – sequence: 3 givenname: Guang surname: Yang fullname: Yang, Guang organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China – sequence: 4 givenname: Yi surname: Tao fullname: Tao, Yi organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China – sequence: 5 givenname: Jun surname: Hou fullname: Hou, Jun organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China – sequence: 6 givenname: Hongwei surname: Xu fullname: Xu, Hongwei organization: Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA 52242, USA – sequence: 7 givenname: Xiaojing surname: Hu fullname: Hu, Xiaojing organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China – sequence: 8 givenname: Ying surname: Han fullname: Han, Ying organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China – sequence: 9 givenname: Qianqiao surname: Zhang fullname: Zhang, Qianqiao organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China – sequence: 10 givenname: Fenghuang surname: Zhan fullname: Zhan, Fenghuang organization: Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA 52242, USA – sequence: 11 givenname: Xiaosong surname: Wu fullname: Wu, Xiaosong email: shijumei@hotmail.com, wuxiaosong@gmail.com organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China shijumei@hotmail.com wuxiaosong@gmail.com – sequence: 12 givenname: Jumei surname: Shi fullname: Shi, Jumei email: shijumei@hotmail.com, wuxiaosong@gmail.com organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China shijumei@hotmail.com wuxiaosong@gmail.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24850305$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kM9Lw0AQhRepWFs9eZfFkyCxO7v51WMpaotVL3oTwuxm0kaSTZtNCv3vTW3taYbHx-PxDVjPVpYYuwHxCGKsRqi1Gy3LVvhwxi4h8gMvkpHodX8YSW8MftBnA-d-hFBhCOKC9aUfB0KJ4JJ9v-2oqErkhorC8Zpc7hq0hnhT8ffXv5gXuy7lJea22PHcbqtiS46j5bPFhJsCneNzL6U12ZRsw0syK7S5K6_YeYaFo-vjHbKv56fP6cxbfLzMp5OFZxSEjadII3TDEMcakASS1KCkL8dSZymgMTqQfpD5EBkESCnOwjiTYOI40hjHasjuD73rutq05JqkzN1-OVqqWpdA4IOKpZJRhz4cUFNXztWUJes6L7HeJSCSvc5krzM56Ozo22Nxq0tKT-y_vw64O9atKrvc5HZ5YsJQduZBSvULyjR_KA |
CitedBy_id | crossref_primary_10_3389_fimmu_2020_575609 crossref_primary_10_3389_fimmu_2021_816499 crossref_primary_10_1002_acg2_49 crossref_primary_10_1002_jcp_30575 crossref_primary_10_3390_ijms20143472 crossref_primary_10_1111_bjh_14570 crossref_primary_10_3389_fonc_2022_834072 crossref_primary_10_3389_fimmu_2018_01415 crossref_primary_10_1051_bioconf_20225501010 crossref_primary_10_3389_fimmu_2018_02848 crossref_primary_10_3389_fonc_2020_01290 crossref_primary_10_3390_cancers12040817 crossref_primary_10_1016_j_ctrv_2018_10_005 crossref_primary_10_1016_j_mam_2021_100968 crossref_primary_10_3389_fonc_2021_731957 crossref_primary_10_3390_ijms23052847 crossref_primary_10_1016_j_ejps_2023_106492 crossref_primary_10_1016_j_jtbi_2018_08_037 |
Cites_doi | 10.1182/blood-2005-09-3671 10.1111/j.1399-0039.2011.01716.x 10.1182/blood-2004-04-1422 10.1182/blood-2007-09-077438 10.1111/j.1365-2141.2008.07340.x 10.1002/eji.200737089 10.1146/annurev.immunol.23.021704.115526 10.1038/87766 10.1007/s00262-013-1493-8 10.1182/blood.V95.2.610 10.1084/jem.184.3.913 10.1016/0092-8674(85)90103-5 10.1073/pnas.86.7.2361 10.1159/000203610 10.1146/annurev.genom.7.080505.115726 10.1182/blood-2007-10-116129 10.1007/s00262-013-1469-8 10.1007/s11864-014-0276-6 10.1038/348213a0 10.1182/blood-2007-09-110312 10.1182/blood-2007-03-078535 10.1182/blood-2011-06-360255 10.1073/pnas.83.15.5688 10.1016/S1499-3872(11)60025-8 10.1038/leu.2008.15 10.1586/17474086.2014.882764 10.4049/jimmunol.159.3.1072 10.1007/BF02827242 10.1073/pnas.94.21.11520 10.1016/j.exphem.2013.01.010 10.1089/152581601750288975 10.1016/S0171-2985(00)80050-9 10.4049/jimmunol.175.8.4866 10.4049/jimmunol.138.6.1657 |
ContentType | Journal Article |
Copyright | The Author 2014. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. |
Copyright_xml | – notice: The Author 2014. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. |
DBID | 2RA 92L CQIGP W94 WU4 ~WA CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1093/abbs/gmu041 |
DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-自然科学 中文科技期刊数据库-自然科学-生物科学 中文科技期刊数据库- 镜像站点 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism |
EISSN | 1745-7270 |
EndPage | 604 |
ExternalDocumentID | 10_1093_abbs_gmu041 24850305 662145122 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -01 -0A -SA -S~ .2P .3N .I3 0R~ 188 1OC 1TH 23M 2RA 31~ 36B 4.4 48X 53G 5GY 5VR 5VS 5XA 5XB 5XL 6J9 70D 8-1 8RM 92L 92M 9D9 9DA AABJS AABMN AAESY AAIJN AAIMJ AAIYJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPQZ AAPXW AAUQX AAVAP AAVLN ABEUO ABIXL ABNKS ABPTD ABQLI ABZBJ ACGFO ACGFS ACUFI ACXQS ACYTK ADBBV ADEIU ADEYI ADFTL ADGZP ADHKW ADHZD ADOCK ADORX ADQLU ADRIX ADRTK ADYVW ADZTZ ADZXQ AECKG AEGPL AEGXH AEJOX AEKKA AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFBPY AFFZL AFIYH AFOFC AFUIB AFXEN AFZJQ AGINJ AGKEF AGSYK AHXPO AIJHB AIKOY AJAOE AJEUX AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALTZX ALUQC APIBT APWMN ARIXL ARQIP AUCZF AXUDD AYOIW AZFZN AZQFJ AZVOD BAWUL BAYMD BCRHZ BEYMZ BFHJK BHONS BQDIO BQUQU BSWAC BTQHN BYORX CAG CAJEA CAJUS CASEJ CCEZO CCVFK CDBKE CHBEP CO8 COF CQIGP CS3 CW9 CZ4 DAKXR DCZOG DIK DILTD DPORF DPPUQ D~K E3Z EBS EE~ EJD EMB EMOBN EX3 F5P F9B FA0 FHSFR FLIZI FLUFQ FOEOM FQBLK GAUVT GJXCC GROUPED_DOAJ GX1 H5~ HAR HH5 HW0 HZ~ IOX J21 JUIAU K97 KOP KSI KSN M-Z M49 N9A NGC NLBLG NMDNZ NU- O9- OAWHX ODMLO OJQWA OJZSN OK1 OVD PAFKI PEELM Q-- Q-0 Q1. Q5Y R-A RD5 ROX RPM RT1 RUSNO RW1 RXO S.. SV3 T8Q TEORI TJP TLC U1F U1G U5A U5K UZ3 UZ4 W2D W94 WOW WU4 X7H YAYTL YKOAZ YXANX ~91 ~WA AAXDM ABXVV CGR CUY CVF ECM EIF H13 NPM AASNB AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c316t-3eba1610aa9b1ae0ae2b1324292bfd1accb5245f417ca11de8f68f21c887ba883 |
ISSN | 1672-9145 |
IngestDate | Fri Oct 25 04:52:28 EDT 2024 Fri Aug 23 02:40:10 EDT 2024 Tue Oct 15 23:50:27 EDT 2024 Wed Feb 14 10:20:49 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | HLA class I natural killer cells myeloma cytotoxicity |
Language | English |
License | The Author 2014. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c316t-3eba1610aa9b1ae0ae2b1324292bfd1accb5245f417ca11de8f68f21c887ba883 |
Notes | Minjie Gao, Lu Gao, Guang Yang, Yi Tao, Jun Hou, Hongwei Xu, Xiaojing Hu, Ying Han, Qianqiao Zhang, Fenghuang Zhan, Xiaosong Wu, and Jumei Shi.1.Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China 2Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA 52242, USA tThese authors contributed equally to this work. *Correspondence address. Tel: + 86-21-66306764; Fax: + 86-21-66301051; E-mail: shijumei@hotmail.com (J.S.)/Tel: + 86-21-66306764; Fax: +86-21-66301051; E-mail: wuxiaosong@gmail.com (X.W.) 31-1940/Q The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell cytotoxicity to myeloma cells remains unclear. In the present study, we investigated the expressions of human leukocyte antigen (HLA) class I and HLA-G in patient myeloma cells, and determined their relevance in patient tumor-cell susceptibility to NK cell cytotoxicity. Our results showed that patient myeloma cells (n = 12) were relatively resistant to NK-92 cell lysis, compared with myeloma cell lines (n = 7, P 〈 0.01). Gene expression profiling and flow cytometry analysis showed that both mRNA and protein of HLA class I were highly expressed in 12 patient mycloma cells. Interestingly, no or low HLA-G surface expression was detected, although multiple HLA-G transcripts were detected in these mycloma cells. NK cell function assay showed that down-regulating HLA class I expression on patient cells by acid treatment significantly increased the susceptibility of MM cells to NK-mediated lysis. Furthermore, we found that the blocking of membrane-bound HLA class I rather than HLA-G using antibodies on myeloma samples markedly increased their susceptibility to NK-mediated killing. These results demonstrated that the resistance of patient MM cells to NK lysis mainly involves an I-ILA class l- dependent mechanism, suggesting that HLA class I may be involved in protecting MM cells from NK-mediated attack and contribute to their immune escape in vivo. myeloma; natural killer cells; cytotoxicity;HLA class I ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24850305 |
PQID | 1541382327 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1541382327 crossref_primary_10_1093_abbs_gmu041 pubmed_primary_24850305 chongqing_primary_662145122 |
PublicationCentury | 2000 |
PublicationDate | 2014-07-01 |
PublicationDateYYYYMMDD | 2014-07-01 |
PublicationDate_xml | – month: 07 year: 2014 text: 2014-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | China |
PublicationPlace_xml | – name: China |
PublicationTitle | Acta biochimica et biophysica Sinica |
PublicationTitleAlternate | Acta Biochimica et Biophysica Sinica |
PublicationYear | 2014 |
References | Ames E (null) 2014; 63 Tinhofer I (null) 2000; 95 Sawanobori M (null) 1997; 98 Shi J (null) 2008; 143 Fan QR (null) 2001; 2 Genadieva-Stavric S (null) 2014 Söderström K (null) 1997; 159 Benson DM (null) 2011; 118 Wang Y (null) 2011; 10 Elliott RL (null) 2011; 26 Kumar SK (null) 2008; 111 Maki G (null) 2008; 22 Cao M (null) 2011; 78 Maki G (null) 2001; 10 Bashirova AA (null) 2006; 7 Liu C (null) 2013; 41 Harel-Bellan A (null) 1986; 83 Laubach JP (null) 2014; 7 Storkus WJ (null) 1987; 138 Lanier LL (null) 2005; 23 Collins SM (null) 2013; 62 Van Bleek GM (null) 1990; 348 Apps R (null) 2007; 37 Rebmann V (null) 2007; 17 Rebmann V (null) 2003; 13 Shi J (null) 2008; 111 Caligiuri MA (null) 2008; 112 Mandelboim O (null) 1996; 184 Rouas-Freiss N (null) 1997; 94 Storkus WJ (null) 1989; 86 Alici E (null) 2008; 111 Beyer M (null) 2006; 107 Carbone E (null) 2005; 105 Townsend AR (null) 1985; 42 Allan DS (null) 2000; 202 Gonen-Gross T (null) 2005; 175 Gong JH (null) 1994; 8 Frassanito MA (null) 1997; 27 |
References_xml | – volume: 107 start-page: 3940 year: 2006 ident: null publication-title: Blood doi: 10.1182/blood-2005-09-3671 contributor: fullname: Beyer M – volume: 78 start-page: 120 year: 2011 ident: null publication-title: Tissue Antigens doi: 10.1111/j.1399-0039.2011.01716.x contributor: fullname: Cao M – volume: 105 start-page: 251 year: 2005 ident: null publication-title: Blood doi: 10.1182/blood-2004-04-1422 contributor: fullname: Carbone E – volume: 8 start-page: 652 year: 1994 ident: null publication-title: Leukemia contributor: fullname: Gong JH – volume: 112 start-page: 461 year: 2008 ident: null publication-title: Blood doi: 10.1182/blood-2007-09-077438 contributor: fullname: Caligiuri MA – volume: 143 start-page: 641 year: 2008 ident: null publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2008.07340.x contributor: fullname: Shi J – volume: 17 start-page: 430 year: 2007 ident: null publication-title: Semin Cell Biol contributor: fullname: Rebmann V – volume: 13 start-page: 371 year: 2003 ident: null publication-title: Semin Cell Biol contributor: fullname: Rebmann V – volume: 37 start-page: 1924 year: 2007 ident: null publication-title: Eur J Immunol doi: 10.1002/eji.200737089 contributor: fullname: Apps R – volume: 23 start-page: 225 year: 2005 ident: null publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.23.021704.115526 contributor: fullname: Lanier LL – volume: 2 start-page: 452 year: 2001 ident: null publication-title: Nat Immunol doi: 10.1038/87766 contributor: fullname: Fan QR – volume: 62 start-page: 1841 year: 2013 ident: null publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-013-1493-8 contributor: fullname: Collins SM – volume: 95 start-page: 610 year: 2000 ident: null publication-title: Blood doi: 10.1182/blood.V95.2.610 contributor: fullname: Tinhofer I – volume: 184 start-page: 913 year: 1996 ident: null publication-title: J Exp Med doi: 10.1084/jem.184.3.913 contributor: fullname: Mandelboim O – volume: 42 start-page: 457 year: 1985 ident: null publication-title: Cell doi: 10.1016/0092-8674(85)90103-5 contributor: fullname: Townsend AR – volume: 86 start-page: 2361 year: 1989 ident: null publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.86.7.2361 contributor: fullname: Storkus WJ – volume: 98 start-page: 150 year: 1997 ident: null publication-title: Acta Haematol doi: 10.1159/000203610 contributor: fullname: Sawanobori M – volume: 7 start-page: 277 year: 2006 ident: null publication-title: Annu Rev Genomics Hum Genet doi: 10.1146/annurev.genom.7.080505.115726 contributor: fullname: Bashirova AA – volume: 111 start-page: 2516 year: 2008 ident: null publication-title: Blood doi: 10.1182/blood-2007-10-116129 contributor: fullname: Kumar SK – volume: 63 start-page: 21 year: 2014 ident: null publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-013-1469-8 contributor: fullname: Ames E – year: 2014 ident: null publication-title: Curr Treat Options Oncol doi: 10.1007/s11864-014-0276-6 contributor: fullname: Genadieva-Stavric S – volume: 348 start-page: 213 year: 1990 ident: null publication-title: Nature doi: 10.1038/348213a0 contributor: fullname: Van Bleek GM – volume: 111 start-page: 3155 year: 2008 ident: null publication-title: Blood doi: 10.1182/blood-2007-09-110312 contributor: fullname: Alici E – volume: 111 start-page: 1309 year: 2008 ident: null publication-title: Blood doi: 10.1182/blood-2007-03-078535 contributor: fullname: Shi J – volume: 118 start-page: 6387 year: 2011 ident: null publication-title: Blood doi: 10.1182/blood-2011-06-360255 contributor: fullname: Benson DM – volume: 83 start-page: 5688 year: 1986 ident: null publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.83.15.5688 contributor: fullname: Harel-Bellan A – volume: 26 start-page: 153 year: 2011 ident: null publication-title: Cancer Biother Radiopharm contributor: fullname: Elliott RL – volume: 10 start-page: 158 year: 2011 ident: null publication-title: Hepatobiliary Pancreat Dis Int doi: 10.1016/S1499-3872(11)60025-8 contributor: fullname: Wang Y – volume: 22 start-page: 998 year: 2008 ident: null publication-title: Leukemia doi: 10.1038/leu.2008.15 contributor: fullname: Maki G – volume: 7 start-page: 97 year: 2014 ident: null publication-title: Expert Rev Hematol doi: 10.1586/17474086.2014.882764 contributor: fullname: Laubach JP – volume: 159 start-page: 1072 year: 1997 ident: null publication-title: J Immunol doi: 10.4049/jimmunol.159.3.1072 contributor: fullname: Söderström K – volume: 27 start-page: 48 year: 1997 ident: null publication-title: Int J Clin Lab Res doi: 10.1007/BF02827242 contributor: fullname: Frassanito MA – volume: 94 start-page: 11520 year: 1997 ident: null publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.94.21.11520 contributor: fullname: Rouas-Freiss N – volume: 41 start-page: 508 year: 2013 ident: null publication-title: Exp Hematol doi: 10.1016/j.exphem.2013.01.010 contributor: fullname: Liu C – volume: 10 start-page: 369 year: 2001 ident: null publication-title: J Hematother Stem Cell Res doi: 10.1089/152581601750288975 contributor: fullname: Maki G – volume: 202 start-page: 34 year: 2000 ident: null publication-title: Immunobiology doi: 10.1016/S0171-2985(00)80050-9 contributor: fullname: Allan DS – volume: 175 start-page: 4866 year: 2005 ident: null publication-title: J Immunol doi: 10.4049/jimmunol.175.8.4866 contributor: fullname: Gonen-Gross T – volume: 138 start-page: 1657 year: 1987 ident: null publication-title: J Immunol doi: 10.4049/jimmunol.138.6.1657 contributor: fullname: Storkus WJ |
SSID | ssj0036610 |
Score | 2.1720614 |
Snippet | The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell... The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell... |
SourceID | proquest crossref pubmed chongqing |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 597 |
SubjectTerms | Cell Line, Tumor Cytotoxicity, Immunologic Down-Regulation Flow Cytometry Gene Expression Profiling HLA Antigens - immunology HLA-G Humans Killer Cells, Natural - immunology Multiple Myeloma - genetics Multiple Myeloma - immunology Multiple Myeloma - pathology NK细胞活性 人类白细胞抗原 依赖性 分子机制 流式细胞仪分析 细胞裂解 骨髓瘤细胞 |
Title | Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism |
URI | http://lib.cqvip.com/qk/90160X/201407/662145122.html https://www.ncbi.nlm.nih.gov/pubmed/24850305 https://search.proquest.com/docview/1541382327 |
Volume | 46 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELeqISReEN-UATISfooy8h3nMR2tyrZOQnSiSEiVnThdpjVhNBEa_yv_C3dxkhUYCHiIY9nOKbn7-XK2fHeEvExsZaGHoplEqTTRtdPkXhqZme8phb6XykXn5NlxMD3xDhb-YjD4tnVqqa7kXvL1Wr-S_5EqtIFc0Uv2HyTbE4UGqIN8oQQJQ_lXMp5dqvNyLQzcfcft_w0agzhTwaA8PmyaDR1yZC3y4hxd_EAbYZxZmNXTo9hI0HY23phdKtzKWCt0Be7iCrZWKxuHLPJYNMEKj1gcsbHP-D6LAqzEr1kMFY-NOOPj6wZvVSKL8e2nAsZjFvtsPGEjIBizMRAZsZGNXUCfh-3jvD90O8uLsxzQLUrjqG5uAPRiZXxoityYQ8tBDV9Y1nAVqy8qNxa1schFeYY7I9MaRuEduPAWpscFdBjNznkzZoPpl97XQGIND747zbd3RmyvP0XbKfMgdECZ63CVe0q3hR6m79XJSlpsh1sK3NenhVtbINCpkX_5zegQXEJKmGuT1bq2dPCunyJ3BwGGgbcdsBBuOKAHg24zSRsKLphGjb9u95qt-ygQx0Rym1eaMAb9OIUPvwDG_Gg8_WZF1FhG8zvkdrukobHG510yUMU9clMnOb28Tz62KKUNSukVSmlV0uPDppk2KKUapbRDKRUFBZTSBqV0C6W0R-kDcjIZz_enZpvTw0xcO6hMV0kBiwxLiEjaQllCOdJGoz5yZJbaIkmk73h-5tlhImw7VTwLeObYCfwMpeDcfUh2irJQjwlVSoZeBuNTnsGyIwCeSSvNMtdNwjC10iHZ7Rm3_KRjtyx7mQxBT7Ws7Dv1gQx3idxfau4PyYuOzUtQvMgSUaiy3ixh7YHxO10nHJJHmv89IYwTiH_SJ398hV1y6wq2T8lO9blWz8DEreTzBijfAfLXmUk |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Myeloma+cells+resistance+to+NK+cell+lysis+mainly+involves+an+HLA+class+I-dependent+mechanism&rft.jtitle=%E7%94%9F%E7%89%A9%E5%8C%96%E5%AD%A6%E4%B8%8E%E7%94%9F%E7%89%A9%E7%89%A9%E7%90%86%E5%AD%A6%E6%8A%A5%EF%BC%9A%E8%8B%B1%E6%96%87%E7%89%88&rft.au=Minjie+Gao+Lu+Gao+Guang+Yang+Yi+Tao+Jun+Hou+Hongwei+Xu+Xiaojing+Hu+Ying+Han+Qianqiao+Zhang+Xiaosong+Wu+Jumei+Shi&rft.date=2014-07-01&rft.issn=1672-9145&rft.eissn=1745-7270&rft.issue=7&rft.spage=597&rft.epage=604&rft_id=info:doi/10.1093%2Fabbs%2Fgmu041&rft.externalDocID=662145122 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90160X%2F90160X.jpg |